PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report) traded up 1.8% during trading on Monday . The stock traded as high as $2.47 and last traded at $2.44. 16,486 shares traded hands during trading, an increase of 87% from the average session volume of 8,831 shares. The stock had previously closed at $2.40.
PharmaCyte Biotech Stock Performance
The company has a 50 day moving average price of $2.71 and a 200 day moving average price of $2.89.
PharmaCyte Biotech Company Profile
PharmaCyte Biotech, Inc is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
Recommended Stories
- Five stocks we like better than PharmaCyte Biotech
- How and Why to Invest in Oil Stocks
- 3 Reasons High-Yield Bloomin’ Brands is About to Blossom
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 5 Computer Vision Stocks with a Clear Path to Growth
- Stocks in the Dow: About the Dow Jones Industrial Average (DJIA)
- 3 Reasons Workday Stock Is Setting Up For A New Rally
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
